Irene Rombel
Chief Executive Officer and Founder
BioCurie

Dr. Irene Rombel is the CEO of BioCurie , which she co – founded with Professor Richard Braatz. Irene is an industry veteran with 25+ years of leadership experience spanning biotechnology, big pharma, consulting, investing, and academia. Prior to BioCurie, she was Chief of Staff, Research, at Spar k Therapeutics; Senior Director of Strategy and External Innovation at Janssen, J&J; Founder and President of Biomedical Intelligence LLC; biotechnology hedge fund analyst; and Assistant Professor at UT Southwestern Medical Center in the Center for Biomedi cal Inventions, where her research focused on DNA vaccines.

Dr. Rombel is on Columbia University’s Translational Therapeutics Accelerator Steering Committee and the Columbia University Irving Cancer Drug Discovery Advisory Board. Her postdoctoral research at UC Berkeley and UC Davis made fundamental scientific contributions to the understanding of transcriptional regulation and promoter – enhancer control of gene expression in mammalian and bacterial systems. Dr. Rombel received her Ph.D. in Biochemistry from the University of Otago, New Zealand, and her MBA from Southern Methodist University, Dallas, Texas. Irene is also a registered U.S. Patent Agent.